External validation of the MAGNIFI-CD index in patients with complex perianal fistulising Crohn's disease.
Kim J BeekLieven G M MuldersKyra L van RijnKarin HorsthuisJeroen A W TielbeekChristianne J BuskensGeert R D'HaensKrisztina B GecseJaap StokerPublished in: European radiology (2024)
Well-defined cut-offs for response and remission are needed for objective treatment monitoring of perianal fistulising Crohn's disease (pfCD). Cut-off values for remission and for response at 6 months follow-up were defined. Interobserver agreement was good. The MAGNIFI-CD index is responsive and reliable for treatment monitoring and is suitable for use in clinical trials.